WAVE — Waverley Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.81m
- CA$3.97m
- CA$0.48m
- 25
- 70
- 40
- 42
Annual cashflow statement for Waverley Pharma, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.706 | -0.797 | -0.664 | -2.22 | -0.947 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.022 | 0.062 | -0.177 | 1.11 | 0.308 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.358 | -0.093 | 0.496 | -0.23 | 0.205 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.362 | -0.799 | -0.237 | -1.02 | -0.41 |
| Other Investing Cash Flow Items | — | — | -0.227 | 0 | -0.612 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -0.227 | 0 | -0.612 |
| Financing Cash Flow Items | -0.414 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.374 | 0.222 | 0.439 | 0.94 | 1.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.767 | -0.552 | -0.024 | -0.081 | 0.183 |